Abdomen CancerNCT07901582
Implementation of a Pain Management Plan in Major Open Abdominal Surgeries.
A study testing Epidural administered opioid in people with Abdomen Cancer and Pancreas Adenocarcinoma (MSI-H), run by National and Kapodistrian University of Athens at 1 site in Greece.
Trial summary
Introduction: Major abdominal surgery encompasses a broad range of surgical procedures in heterogeneous patient populations.Management of postoperative pain has received keen attention in recent years with considerable concurrent advancement in the field.Despite this improvement,postoperative pain continues to be a… Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Abdomen Cancer, Pancreas Adenocarcinoma (MSI-H), Colectomy Left/Right/Total Under Laparotomy
- What is being tested?
- Epidural administered opioid
- Type of treatment
- Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 58 participants
- Where
- 1 siteGreece
- Study dates
- 22 Nov 2025to Nov 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Elective surgical patients admitted for open abdominal surgeries.
- -
Who cannot join
- Coagulation disorders. Demyelinating disorders of the CNS. Severe hemodynamic instability requiring vasopressors from the early beginning of the surgery. Reported allergic reaction to local anaesthetics Objection to take part.
- -
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Greece1 site, 1 recruiting
- Recruiting
Evangelismos General Hospital
Athens, Athens, 10676
MARIA ZACHARIADI, MEDICAL DOCTOR, +35799760521, maria11095@yahoo.gr
About this study
Introduction:
Major abdominal surgery encompasses a broad range of surgical procedures in heterogeneous patient populations.Management of postoperative pain has received keen attention in recent years with considerable concurrent advancement in the field.Despite this improvement,postoperative pain continues to be a challenge since suboptimal postoperative pain control is a risk factor for persistent surgical pain,increased morbidity,poorer functional recovery and reduced quality of life.Therefore,analgesic strategies should regard patients' factors as well as surgical procedures peculiarities.Since efforts are made throughout the years and are of utmost importance as numerous analgesic options exist for the effective pain control after abdominal surgeries including multiple classes of drugs and routes of administration(i.e.parenteral,regional,neuraxia.)In the context of the current surgical environment where improvement has been made,emphasis is placed on precision,minimizing trauma and improving the outcome.The choice of postoperative pain analgesic modality,is at the discretion of the primary anaesthesiologist and the choice depends upon the plan favored by him/her as well as the availability of drugs and equipment.Continuous re-evaluation of analgesic strategies is a necessary step toward establishing a better pain management plan in major abdominal surgeries and to design guidelines to improve our clinical approach.
Read more
Study Objective:
The target of the study is to compare the outcome of the selected analgesic combination of local anaesthetic and opioid(ropivacaine+fentanyl or ropivacaine +morphine)for postoperative continuous infusion,aiming to relief successfully the pain,on patients undergoing major abdominal surgeries based on hemodynamic and clinical findings.
The study aims to highlight the positive impact of the chosen analgesic combination during the intraoperative period,the postoperative recovery period and also during the follow up periods in terms of physical function,pain intensity during activity,adverse effects and self efficacy.
Methods:
The study is prospective,comparative aiming to identify the pain management agents that will provide the best postoperative relief in order to be established and used as a primary choice to patients undergoing major open abdominal surgeries .All patients included will receive the same analgesic technique(epidural)chosen preoperatively by the anaesthesiologist in charge.All study participants are informed in detail and written informed consent is obtained.The study is in accordance with the regulations of the Declaration of Helsinki on human studies and the Greek legislation.
The investigators will study 58 patients,equally divided into two groups, aged 18-80 years,administered to Evangelismos General hospital,Athens-Greece, for elective open abdominal surgeries.
In group A(p:29),the investigators will administer for postoperative pain relief - Ropivacaine 200 ml/400 mg + Fentanyl for continuous epidural infusion for the first 5 days.The infusion will start 2 hours before the end of the operation and before the admission to the intensive care unit.
In group B(p:29),the investigators will administer for postoperative pain relief Ropivacaine 200ml/400mg + Morphine for continuous epidural infusion for the first 5 days.The infusion will start 2 hours before the end of the operation and before the admission to the intensive care unit.
Read the detailed description
1.Abstract Major abdominal surgery encompasses a broad range of surgical procedures in heterogenous patient populations.Management of postoperative pain has received keen attention in recent years with considerable concurrent advancement in the field.Despite this improvement,postoperative pain continues to be a challenge since suboptimal postoperative pain control is a risk factor for persistent surgical pain,increased morbidity,poorer functional recovery and reduced quality of life.Therefore,analgesic strategies should regard patients' factors as well as surgical procedures peculiarities.Since efforts are made throughout the years and are of utmost importance as numerous analgesic options exist for the effective pain control after abdominal surgeries including multiple classes of drugs and routes of administration (i.e.parenteral,regional,neuraxia.).Within the broad category of major abdominal surgery,upper gastrointestinal surgery is frequently associated with the greatest surgical insult and resultant higher intensity of postoperative pain.For example,a recent systemic review of epidural analgesia in patients undergoing pancreatoduodenectomy in 2019,among a large number of patients,the reported results show lower postoperative pain scores,lower complication rates,decreased hospital length of stay as well as mortality.In the context of the current surgical environment where improvement has been made,emphasis is placed on precision,minimizing trauma and improving the outcome.The choice of postoperative pain analgesic modality,is at the discretion of the primary anaesthesiologist and the choice depends upon the plan favored by him/her as well as the availability of drugs and equipment.Continuous re-evaluation of analgesic strategies is a necessary step toward establishing a better pain management plan in major abdominal surgeries and to design guidelines to improve our clinical approach.
1A.Patient selection criteria: A demanding factor in the ultimate fulfillment of this operation and cure, is proper selection of candidates,requiring a thorough evaluation for the presence of metastasis,confirming any disease beyond TME(Total mesorectal excision)requiring multivisceral or pelvic excision.A chest X-ray and computed tomographic (CT) scan of the pelvis and abdomen are the minimal tests necessary for the evaluation. The CT scan provides evaluation of the liver, retroperitoneal lymph nodes, and urinary tract and allows better evaluation of sidewall involvement by the tumor in the pelvis.Loss of tissue planes in the lateral pelvis indicates invasion of the tumor into the pelvic musculature.The absolute and relative contraindications to open abdominal surgeries vary.A study by Huang and colleagues regarding pelvic exenteration surgeries,describe that duration of surgery,blood loss,length of hospital stay and complication rates did not increase with age.Advanced age has been considered a relative contraindication to exenterative surgery,probably because older patients are more likely to have pre-existing medical conditions,eg:heart disease,COPD,decreased renal function and altered immunologic response.Advanced chronological age should not be considered a contraindication to potentially curative surgical procedure.
1B.Preoperative assessment: The aims of preoperative assessment should be determining the level of surgical fitness,ascertaining functional reserve and the ability to withstand periods of significant physiological stress,the identification of issues that can potentially result in adverse surgical and anaesthetic outcomes.Given the inherent risk involved in surgical procedure,appropriate anaesthetist-led assessment and management of various co-morbid conditions in the perioperative period,at least 1 week before the arranged date of the surgery,can considerably improve patient safety,especially among high risk patients.Generally,the high risk patients have medical comorbidities,eg:ischemic heart disease,heart failure,valvular heart disease,cardiac implantable electronic device,pulmonary disease,and diabetes mellitus.It has been suggested,that are defined as high risk patients,those with mortality risk greater than 5% and those undergoing a procedure carrying a mortality risk of >5%.Over the years anaesthetist work extended,to assessing the risk of anaesthesia,optimizing comorbid conditions,selecting patients who may benefit from additional regional techniques and identifying potential difficulties that may be encountered during operation as well as postoperative period.Cardiopulmonary exercise test(CPET),gives an integrated objective measure of functional capacity which in turn is a strong predictor of postoperative morbidity and mortality.Thus,determining the functional capacity is a mandatory step in preoperative assessment and is measured in METS(metabolic equivalent of tasks,goal:>4).Additionally,the revised cardiac index,is the most approved system,since cardiovascular complications are one of the leading cause of postoperative mortality and morbidity.Οptimisation of lung function helps in reducing complications. Patients are advised to stop smoking for a period of 4-6 weeks,aiming in reduction of airway reactivity, improve mucociliary function and decrease carboxy-haemoglobin. The widely used incentive spirometry may be useful only when combined with other respiratory muscle exercises.Pharmacotherapy of asthma and chronic obstructive pulmonary disease must be optimised before considering the patient for elective surgery. Beta 2 agonists, inhaled corticosteroids and systemic corticosteroids, are the main drugs used for this.Also,the ARISCAT score can be included in the preoperative assessment ,in order to predict risk of pulmonary complications after surgery.
1C.Perioperative Management: Considering the nature of the surgeries and its duration,general anaesthesia is compulsory.Selection of the most suitable haemodynamic and respiratory intraoperative methods,and appropriate assimilation of these,may help apprehend its status and avoid over resuscitation.Antibiotic prophylaxis should cover both aerobic and anaerobic bacteria,based on the patient's allergy status.Furthermore,hypothermia should be prevented,using various warming systems,which in turn can result in coagulopathy,immune function suppression,cardiac and infective complications.Pressure-related neuropathy,especially among patients undergone chemoradiotherapy,can be a consequence of the nerve subjected to stretch,compression,ischaemia,trauma or a combination of these factors.Expecting possible massive haemorrhage,presents one more challenge to the anaesthetist.Due to this possibility,blood products must be ready for immediate use.
- D.Pain management: Last,but the most important pain must be considered.Cancer related pain,is a common symptom and an unavoidable outcome of cancer which affects the quality of life and the postoperative survival.Cancer patients,experience pain due to disease progression and/or treatment(chemotherapy-radiotherapy).Thus, pain management process should start from the preoperative assessment aiming in its optimization during intraoperative and postoperative period.Apart from the interpersonal differences in pain experience,the pain intensity varies based on the different surgical approach,size of incisions,type of surgery(+bone resection) and reconstructive procedure performed.Epidural analgesia,remains the cornerstone of postoperative pain control.Moreover,there are many published benefits including decrease of the surgical stress response,in particular neuroendocrine(sympathetic and pituitary)and metabolic (hyperglycemia and protein catabolism)effects,reduced pulmonary complications(hypoxia,atelectasis,thromboembolism)and some evidence of reduced incidence of myocardial infarction and acute kidney injury.Additionally,epidural analgesia reduces both opioid consumption and it has been shown that maintains the immune functions of patients and is associated with a decrease in tumor recurrence. It has also been shown to reduce hypercoagulability,increases exercise capacity and accelerates the return of intestinal functions to normal. In line with this information in colorectal surgery specifically ERAS guidelines advocate the use of epidural.In addition,multimodal analgesia has become popular through the years and in a sense,is a way of intervening to prevent pain from being experienced or reducing the pain felt to a level accepted by the patients.However,the is no conclusive evidence to support opioid avoidance with the goal to minimize the risk of cancer recurrence. The target of the study is to compare the outcome of the selected analgesic combination of local anaesthetic and opioid(ropivacaine+fentanyl or ropivacaine +morphine)for postoperative continuous infusion,aiming to relief successfully the pain,on patients undergoing major abdominal surgeries based on hemodynamic,clinical and questionnaire findings.All patients included will receive the same: preoperative pain assessment -using VRS scale- method of central neuraxial block -epidural- size of Tuohy needle level of epidural catheter placement based on nature of the surgery(thoracic or lumbar region) plan of anaesthesia -General anaesthesia(Desflurane) + remifentanil quantity of intravenous opioids intraoperatively -remifentanil,fentanyl,morphine- local anaesthetic solution-ropivacaine 200ml/400mg- The study is a prospective,comparative of two analgesic options.The investigators,will study 58 patients,equally divided into two groups, aged 18-80 years,administered to the hospital for elective open abdominal surgeries. The study aims to highlight the positive impact of the chosen analgesic combination during the intraoperative period,the postoperative recovery period and also during the follow up periods in terms of physical function,pain intensity during activity,adverse effects and self efficacy.More than that,the key is to minimise the side effects of the method chosen and to achieve early mobilization. Historically, epidural analgesia has the strongest evidence base for open abdominal surgery. They have been well studied for over 20 years and provide excellent static and dynamic analgesia provided they work.There are many published benefits many mentioned above.However, epidural analgesia is not without its own setbacks and these have been garnering increasing attention that potentially challenges the view that they are the gold standard for open abdominal surgery. Epidural failure for whatever reason (incorrect primary placement, secondary catheter migration and suboptimal dosing) is one of the most common complications and has been quoted as occurring in 27-32% of cases. Hypotension and motor block may lead to excessive intravenous fluid administration and impaired mobilisation respectively. There is a significantly increased risk of pruritus and urinary retention while,more serious rare complications include epidural haematoma and abscess formation.The current available evidence tends to highlight more benefits than risks.
- A.Objectives Primary Epidural continuous infusion combination(ropivacaine +fentanyl or morphine) potent pain control using VRS scale (>4 considered as poor analgesic outcome.) Secondary Preoperative Analgesia Intraoperative Analgesia Hypotensive episodes Vasopresor use Fluid Resuscitation Duration of surgery Postoperative pain intensity during 5 first days during rest\&cough Additional analgesic admin. Desaturation Episodes Sp02<94% Nausea/Vomiting episodes Mobilization time Bower recovery time ICU length of stay Hospital length of stay
- A.Inclusion Elective surgical patients admitted to ''Evangelismos General Hospital'' for open abdominal surgeries.
3B.Exclusion
Surgical patients will be excluded if they have:
Coagulation disorders. Demyelinating disorders of the CNS. Severe hemodynamic instability requiring vasopressors from the early beginning of the surgery.
Reported allergic reaction to local anaesthetics. Objection to take part.
3C.Parameters Patients Demographics Age Gender Ethnicity BMI calculation ASA Medical History Operations and any reported complications Comorbidities(i.e.Cardiovascular/Respiratory) Medications Smoking GERD Chemotherapy/Radiotherapy (number of cycles and last cycle) Pain score during preoperative assessment NRS score
Preoperative,intraoperative and postoperative data are collected.
Preoperatively,a clinical examination is performed and the laboratory findings are gathered.Based on preoperative medical examination any further examinations may be requested.
Intraoperatively,the following parameters will be continuous recorder:
Hemodynamic parameters (i.e. heart rate,mean arterial pressure,SpO2,CO,CI,SVV,HPI,BIS,CVP)before induction,immediately after induction,during the first 6-7h and during the end of the process.
Quantitative measurement of the administered anaesthetics,opioids,fluids,vasopressors and inotropic drugs. Intraoperative complications (i.e. bleeding,hypotension). Duration of the surgery.
Postoperatively,the following data will be recorded:
Postoperative pain will be recorded during the first 5 days after surgery,using the NRS scale (0-no pain/10-severe pain)in rest and during cough.Considered to have the expected good pain relief will report mean pain score during the first 72 hours between 0-4,graded as fair pain relief in patients with a mean pain score between 4,and as poor pain relief a mean pain score between 5-10.
Additional pain medications required. Episodes of desaturation SpO2 <94%. Postoperative nausea \& vomiting. Time required until mobilization. Time required for intestinal function. ICU length of stay. Complications. QoR-4(quality of recovery),2 weeks and 2 months postoperative. Total hospital length of stay.
Power analysis determination is described below:
Exact - Proportions: Inequality, two independent groups (Fisher's exact test) Options: Exact distribution Analysis: A priori: Compute required sample size Input: Tail(s) = Two Proportion p1 = 0.1 Proportion p2 = 0.45 α err prob = 0.05 Power (1-β err prob) = 0.80 Allocation ratio N2/N1 = 1 Output: Sample size group 1 = 29 Sample size group 2 = 29 Total sample size = 58 Actual power = 0.8106139
4.Expected Results Our study inquires into the choice of the best analgesic technique and medication combination in order to relieve pain related to cancer.Epidural technique, is a reliable method which will provide the most effective pain minimization,hemodynamic stability and reduction of intraoperative and postoperative complications.Moreover,postoperative pain relief ,besides being humanitarian,aims to improve patient's psychological,cardiovascular as well as respiratory function.The awareness of all the above is first in order of importance,for anesthesiologists and specialists involved in this particular type of surgery.Predicted cancer mortality rates remain favorable in the EU and UK and attention should be pain to the predicted increases in CRC mortality in young adults.Specifically,pelvic exenterations are newly introduced in Greece but they are evolving constantly world widely i.e.England,Australia. since the first surgery in 1948.And while,epidural technique is proposed to these patients,taking into account the detailed knowledge of all the factors the investigators can provide pain control while minimizing the side effects.
- Conditions
- Abdomen Cancer, Pancreas Adenocarcinoma (MSI-H), Colectomy Left/Right/Total Under Laparotomy, Hepatectomy, Nephrectomy, Esophagectomy
- Being tested
- Epidural administered opioid
- Keywords
- open abdominal surgeries, analgesia, epidural, opioids, pain, cancer
- Medical subject headings
- Pelvic Neoplasms, Enteritis, Adrenal Cortex Neoplasms, Agnosia, Pain, Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Epidural administered opioidProcedure or surgery
Also called Epidural, Opioid administration, Fentanyl, Ropivacaine combination withe opioid
Postoperative analgesic combination - Ropivacaine 200 ml/400 mg + Fentanyl for continuous epidural infusion for the first 5 days.The infusion will start 2 hours before the end of the operation and before the admission to the intensive care unit.
Epidural administered opioidProcedure or surgery
Also called Opioid, Epidural space, Postoperative complications, Respiratory Depression
Postoperative analgesic combination - Ropivacaine 200 ml/400 mg + Morphine for continuous epidural infusion for the first 5 days.The infusion will start 2 hours before the end of the operation and before the admission to the intensive care unit.
| Study group | Role | What they receive |
|---|---|---|
| Analgesic Combination-Fentanyl&Ropivacaine 0.2% | Other | The selected analgesic combination of local anaesthetic and opioid for postoperative continuous infusion,aiming to relief successfully the pain. Receives: Procedure: Epidural administered opioid |
| Analgesic Combination-Morphine&Ropivacaine 0.2% | Other | The selected analgesic combination of local anaesthetic and opioid for postoperative continuous infusion,aiming to relief successfully the pain. Receives: Procedure: Epidural administered opioid |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain Relief
Using the NRS scale the analgesic combination outcome will be measured and reported with zero being equivalent to no pain and ten being the worst possible pain.
Measured: From first postoperative day to the fifth postoperative day.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Oct 2026
- Study start22 Nov 2025
- Primary completion20 Sep 2027 (estimated)
- Study completionNov 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Abdomen CancerStudies of the same condition, open and under way.
- More trials run by National and Kapodistrian University of AthensThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 58 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National and Kapodistrian University of Athens
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Maria Zachariadi, National and Kapodistrian University of Athens
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07901582
- Sponsor's protocol ID
- 145840
- Status last verified
- Oct 2026
- First submitted
- 22 Oct 2026
- Last updated
- 30 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 30 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Implementation of a Pain Management Plan in Major Open Abdominal Surgeries.
- ClinicalTrials.gov ID
- NCT07901582
- Acronym / sponsor ID
- 145840
- Conditions
- Abdomen Cancer, Pancreas Adenocarcinoma (MSI-H), Colectomy Left/Right/Total Under Laparotomy, Hepatectomy, Nephrectomy, Esophagectomy
- Keywords
- open abdominal surgeries, analgesia, epidural, opioids, pain, cancer
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 58 participants (estimated)
- Lead sponsor
- National and Kapodistrian University of AthensUniversity, hospital or other
- Study start
- 22 Nov 2025 (actual)
- Primary completion
- 20 Sep 2027 (estimated)
- Study completion
- Nov 2027 (estimated)
- First posted
- 28 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Introduction:
Major abdominal surgery encompasses a broad range of surgical procedures in heterogeneous patient populations.Management of postoperative pain has received keen attention in recent years with considerable concurrent advancement in the field.Despite this improvement,postoperative pain continues to be a challenge since suboptimal postoperative pain control is a risk factor for persistent surgical pain,increased morbidity,poorer functional recovery and reduced quality of life.Therefore,analgesic strategies should regard patients' factors as well as surgical procedures peculiarities.Since efforts are made throughout the years and are of utmost importance as numerous analgesic options exist for the effective pain control after abdominal surgeries including multiple classes of drugs and routes of administration(i.e.parenteral,regional,neuraxia.)In the context of the current surgical environment where improvement has been made,emphasis is placed on precision,minimizing trauma and improving the outcome.The choice of postoperative pain analgesic modality,is at the discretion of the primary anaesthesiologist and the choice depends upon the plan favored by him/her as well as the availability of drugs and equipment.Continuous re-evaluation of analgesic strategies is a necessary step toward establishing a better pain management plan in major abdominal surgeries and to design guidelines to improve our clinical approach.
Study Objective:
The target of the study is to compare the outcome of the selected analgesic combination of local anaesthetic and opioid(ropivacaine+fentanyl or ropivacaine +morphine)for postoperative continuous infusion,aiming to relief successfully the pain,on patients undergoing major abdominal surgeries based on hemodynamic and clinical findings.
The study aims to highlight the positive impact of the chosen analgesic combination during the intraoperative period,the postoperative recovery period and also during the follow up periods in terms of physical function,pain intensity during activity,adverse effects and self efficacy.
Methods:
The study is prospective,comparative aiming to identify the pain management agents that will provide the best postoperative relief in order to be established and used as a primary choice to patients undergoing major open abdominal surgeries .All patients included will receive the same analgesic technique(epidural)chosen preoperatively by the anaesthesiologist in charge.All study participants are informed in detail and written informed consent is obtained.The study is in accordance with the regulations of the Declaration of Helsinki on human studies and the Greek legislation.
The investigators will study 58 patients,equally divided into two groups, aged 18-80 years,administered to Evangelismos General hospital,Athens-Greece, for elective open abdominal surgeries.
In group A(p:29),the investigators will administer for postoperative pain relief - Ropivacaine 200 ml/400 mg + Fentanyl for continuous epidural infusion for the first 5 days.The infusion will start 2 hours before the end of the operation and before the admission to the intensive care unit.
In group B(p:29),the investigators will administer for postoperative pain relief Ropivacaine 200ml/400mg + Morphine for continuous epidural infusion for the first 5 days.The infusion will start 2 hours before the end of the operation and before the admission to the intensive care unit.
Detailed description
1.Abstract Major abdominal surgery encompasses a broad range of surgical procedures in heterogenous patient populations.Management of postoperative pain has received keen attention in recent years with considerable concurrent advancement in the field.Despite this improvement,postoperative pain continues to be a challenge since suboptimal postoperative pain control is a risk factor for persistent surgical pain,increased morbidity,poorer functional recovery and reduced quality of life.Therefore,analgesic strategies should regard patients' factors as well as surgical procedures peculiarities.Since efforts are made throughout the years and are of utmost importance as numerous analgesic options exist for the effective pain control after abdominal surgeries including multiple classes of drugs and routes of administration (i.e.parenteral,regional,neuraxia.).Within the broad category of major abdominal surgery,upper gastrointestinal surgery is frequently associated with the greatest surgical insult and resultant higher intensity of postoperative pain.For example,a recent systemic review of epidural analgesia in patients undergoing pancreatoduodenectomy in 2019,among a large number of patients,the reported results show lower postoperative pain scores,lower complication rates,decreased hospital length of stay as well as mortality.In the context of the current surgical environment where improvement has been made,emphasis is placed on precision,minimizing trauma and improving the outcome.The choice of postoperative pain analgesic modality,is at the discretion of the primary anaesthesiologist and the choice depends upon the plan favored by him/her as well as the availability of drugs and equipment.Continuous re-evaluation of analgesic strategies is a necessary step toward establishing a better pain management plan in major abdominal surgeries and to design guidelines to improve our clinical approach.
1A.Patient selection criteria: A demanding factor in the ultimate fulfillment of this operation and cure, is proper selection of candidates,requiring a thorough evaluation for the presence of metastasis,confirming any disease beyond TME(Total mesorectal excision)requiring multivisceral or pelvic excision.A chest X-ray and computed tomographic (CT) scan of the pelvis and abdomen are the minimal tests necessary for the evaluation. The CT scan provides evaluation of the liver, retroperitoneal lymph nodes, and urinary tract and allows better evaluation of sidewall involvement by the tumor in the pelvis.Loss of tissue planes in the lateral pelvis indicates invasion of the tumor into the pelvic musculature.The absolute and relative contraindications to open abdominal surgeries vary.A study by Huang and colleagues regarding pelvic exenteration surgeries,describe that duration of surgery,blood loss,length of hospital stay and complication rates did not increase with age.Advanced age has been considered a relative contraindication to exenterative surgery,probably because older patients are more likely to have pre-existing medical conditions,eg:heart disease,COPD,decreased renal function and altered immunologic response.Advanced chronological age should not be considered a contraindication to potentially curative surgical procedure.
1B.Preoperative assessment: The aims of preoperative assessment should be determining the level of surgical fitness,ascertaining functional reserve and the ability to withstand periods of significant physiological stress,the identification of issues that can potentially result in adverse surgical and anaesthetic outcomes.Given the inherent risk involved in surgical procedure,appropriate anaesthetist-led assessment and management of various co-morbid conditions in the perioperative period,at least 1 week before the arranged date of the surgery,can considerably improve patient safety,especially among high risk patients.Generally,the high risk patients have medical comorbidities,eg:ischemic heart disease,heart failure,valvular heart disease,cardiac implantable electronic device,pulmonary disease,and diabetes mellitus.It has been suggested,that are defined as high risk patients,those with mortality risk greater than 5% and those undergoing a procedure carrying a mortality risk of >5%.Over the years anaesthetist work extended,to assessing the risk of anaesthesia,optimizing comorbid conditions,selecting patients who may benefit from additional regional techniques and identifying potential difficulties that may be encountered during operation as well as postoperative period.Cardiopulmonary exercise test(CPET),gives an integrated objective measure of functional capacity which in turn is a strong predictor of postoperative morbidity and mortality.Thus,determining the functional capacity is a mandatory step in preoperative assessment and is measured in METS(metabolic equivalent of tasks,goal:>4).Additionally,the revised cardiac index,is the most approved system,since cardiovascular complications are one of the leading cause of postoperative mortality and morbidity.Οptimisation of lung function helps in reducing complications. Patients are advised to stop smoking for a period of 4-6 weeks,aiming in reduction of airway reactivity, improve mucociliary function and decrease carboxy-haemoglobin. The widely used incentive spirometry may be useful only when combined with other respiratory muscle exercises.Pharmacotherapy of asthma and chronic obstructive pulmonary disease must be optimised before considering the patient for elective surgery. Beta 2 agonists, inhaled corticosteroids and systemic corticosteroids, are the main drugs used for this.Also,the ARISCAT score can be included in the preoperative assessment ,in order to predict risk of pulmonary complications after surgery.
1C.Perioperative Management: Considering the nature of the surgeries and its duration,general anaesthesia is compulsory.Selection of the most suitable haemodynamic and respiratory intraoperative methods,and appropriate assimilation of these,may help apprehend its status and avoid over resuscitation.Antibiotic prophylaxis should cover both aerobic and anaerobic bacteria,based on the patient's allergy status.Furthermore,hypothermia should be prevented,using various warming systems,which in turn can result in coagulopathy,immune function suppression,cardiac and infective complications.Pressure-related neuropathy,especially among patients undergone chemoradiotherapy,can be a consequence of the nerve subjected to stretch,compression,ischaemia,trauma or a combination of these factors.Expecting possible massive haemorrhage,presents one more challenge to the anaesthetist.Due to this possibility,blood products must be ready for immediate use.
- D.Pain management: Last,but the most important pain must be considered.Cancer related pain,is a common symptom and an unavoidable outcome of cancer which affects the quality of life and the postoperative survival.Cancer patients,experience pain due to disease progression and/or treatment(chemotherapy-radiotherapy).Thus, pain management process should start from the preoperative assessment aiming in its optimization during intraoperative and postoperative period.Apart from the interpersonal differences in pain experience,the pain intensity varies based on the different surgical approach,size of incisions,type of surgery(+bone resection) and reconstructive procedure performed.Epidural analgesia,remains the cornerstone of postoperative pain control.Moreover,there are many published benefits including decrease of the surgical stress response,in particular neuroendocrine(sympathetic and pituitary)and metabolic (hyperglycemia and protein catabolism)effects,reduced pulmonary complications(hypoxia,atelectasis,thromboembolism)and some evidence of reduced incidence of myocardial infarction and acute kidney injury.Additionally,epidural analgesia reduces both opioid consumption and it has been shown that maintains the immune functions of patients and is associated with a decrease in tumor recurrence. It has also been shown to reduce hypercoagulability,increases exercise capacity and accelerates the return of intestinal functions to normal. In line with this information in colorectal surgery specifically ERAS guidelines advocate the use of epidural.In addition,multimodal analgesia has become popular through the years and in a sense,is a way of intervening to prevent pain from being experienced or reducing the pain felt to a level accepted by the patients.However,the is no conclusive evidence to support opioid avoidance with the goal to minimize the risk of cancer recurrence. The target of the study is to compare the outcome of the selected analgesic combination of local anaesthetic and opioid(ropivacaine+fentanyl or ropivacaine +morphine)for postoperative continuous infusion,aiming to relief successfully the pain,on patients undergoing major abdominal surgeries based on hemodynamic,clinical and questionnaire findings.All patients included will receive the same: preoperative pain assessment -using VRS scale- method of central neuraxial block -epidural- size of Tuohy needle level of epidural catheter placement based on nature of the surgery(thoracic or lumbar region) plan of anaesthesia -General anaesthesia(Desflurane) + remifentanil quantity of intravenous opioids intraoperatively -remifentanil,fentanyl,morphine- local anaesthetic solution-ropivacaine 200ml/400mg- The study is a prospective,comparative of two analgesic options.The investigators,will study 58 patients,equally divided into two groups, aged 18-80 years,administered to the hospital for elective open abdominal surgeries. The study aims to highlight the positive impact of the chosen analgesic combination during the intraoperative period,the postoperative recovery period and also during the follow up periods in terms of physical function,pain intensity during activity,adverse effects and self efficacy.More than that,the key is to minimise the side effects of the method chosen and to achieve early mobilization. Historically, epidural analgesia has the strongest evidence base for open abdominal surgery. They have been well studied for over 20 years and provide excellent static and dynamic analgesia provided they work.There are many published benefits many mentioned above.However, epidural analgesia is not without its own setbacks and these have been garnering increasing attention that potentially challenges the view that they are the gold standard for open abdominal surgery. Epidural failure for whatever reason (incorrect primary placement, secondary catheter migration and suboptimal dosing) is one of the most common complications and has been quoted as occurring in 27-32% of cases. Hypotension and motor block may lead to excessive intravenous fluid administration and impaired mobilisation respectively. There is a significantly increased risk of pruritus and urinary retention while,more serious rare complications include epidural haematoma and abscess formation.The current available evidence tends to highlight more benefits than risks.
- A.Objectives Primary Epidural continuous infusion combination(ropivacaine +fentanyl or morphine) potent pain control using VRS scale (>4 considered as poor analgesic outcome.) Secondary Preoperative Analgesia Intraoperative Analgesia Hypotensive episodes Vasopresor use Fluid Resuscitation Duration of surgery Postoperative pain intensity during 5 first days during rest\&cough Additional analgesic admin. Desaturation Episodes Sp02<94% Nausea/Vomiting episodes Mobilization time Bower recovery time ICU length of stay Hospital length of stay
- A.Inclusion Elective surgical patients admitted to ''Evangelismos General Hospital'' for open abdominal surgeries.
3B.Exclusion
Surgical patients will be excluded if they have:
Coagulation disorders. Demyelinating disorders of the CNS. Severe hemodynamic instability requiring vasopressors from the early beginning of the surgery.
Reported allergic reaction to local anaesthetics. Objection to take part.
3C.Parameters Patients Demographics Age Gender Ethnicity BMI calculation ASA Medical History Operations and any reported complications Comorbidities(i.e.Cardiovascular/Respiratory) Medications Smoking GERD Chemotherapy/Radiotherapy (number of cycles and last cycle) Pain score during preoperative assessment NRS score
Preoperative,intraoperative and postoperative data are collected.
Preoperatively,a clinical examination is performed and the laboratory findings are gathered.Based on preoperative medical examination any further examinations may be requested.
Intraoperatively,the following parameters will be continuous recorder:
Hemodynamic parameters (i.e. heart rate,mean arterial pressure,SpO2,CO,CI,SVV,HPI,BIS,CVP)before induction,immediately after induction,during the first 6-7h and during the end of the process.
Quantitative measurement of the administered anaesthetics,opioids,fluids,vasopressors and inotropic drugs. Intraoperative complications (i.e. bleeding,hypotension). Duration of the surgery.
Postoperatively,the following data will be recorded:
Postoperative pain will be recorded during the first 5 days after surgery,using the NRS scale (0-no pain/10-severe pain)in rest and during cough.Considered to have the expected good pain relief will report mean pain score during the first 72 hours between 0-4,graded as fair pain relief in patients with a mean pain score between 4,and as poor pain relief a mean pain score between 5-10.
Additional pain medications required. Episodes of desaturation SpO2 <94%. Postoperative nausea \& vomiting. Time required until mobilization. Time required for intestinal function. ICU length of stay. Complications. QoR-4(quality of recovery),2 weeks and 2 months postoperative. Total hospital length of stay.
Power analysis determination is described below:
Exact - Proportions: Inequality, two independent groups (Fisher's exact test) Options: Exact distribution Analysis: A priori: Compute required sample size Input: Tail(s) = Two Proportion p1 = 0.1 Proportion p2 = 0.45 α err prob = 0.05 Power (1-β err prob) = 0.80 Allocation ratio N2/N1 = 1 Output: Sample size group 1 = 29 Sample size group 2 = 29 Total sample size = 58 Actual power = 0.8106139
4.Expected Results Our study inquires into the choice of the best analgesic technique and medication combination in order to relieve pain related to cancer.Epidural technique, is a reliable method which will provide the most effective pain minimization,hemodynamic stability and reduction of intraoperative and postoperative complications.Moreover,postoperative pain relief ,besides being humanitarian,aims to improve patient's psychological,cardiovascular as well as respiratory function.The awareness of all the above is first in order of importance,for anesthesiologists and specialists involved in this particular type of surgery.Predicted cancer mortality rates remain favorable in the EU and UK and attention should be pain to the predicted increases in CRC mortality in young adults.Specifically,pelvic exenterations are newly introduced in Greece but they are evolving constantly world widely i.e.England,Australia. since the first surgery in 1948.And while,epidural technique is proposed to these patients,taking into account the detailed knowledge of all the factors the investigators can provide pain control while minimizing the side effects.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Analgesic Combination-Fentanyl&Ropivacaine 0.2% | Other | Procedure: Epidural administered opioidThe selected analgesic combination of local anaesthetic and opioid for postoperative continuous infusion,aiming to relief successfully the pain. |
| Analgesic Combination-Morphine&Ropivacaine 0.2% | Other | Procedure: Epidural administered opioidThe selected analgesic combination of local anaesthetic and opioid for postoperative continuous infusion,aiming to relief successfully the pain. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Elective surgical patients admitted for open abdominal surgeries.
- -
Key exclusion criteria (2 listed)
- Coagulation disorders. Demyelinating disorders of the CNS. Severe hemodynamic instability requiring vasopressors from the early beginning of the surgery. Reported allergic reaction to local anaesthetics Objection to take part.
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Epidural administered opioidAlso: Epidural, Opioid administration, Fentanyl, Ropivacaine combination withe opioidPostoperative analgesic combination - Ropivacaine 200 ml/400 mg + Fentanyl for continuous epidural infusion for the first 5 days.The infusion will start 2 hours before the end of the operation and before the admission to the intensive care unit. | Procedure or surgery | Analgesic Combination-Fentanyl&Ropivacaine 0.2% |
| Epidural administered opioidAlso: Opioid, Epidural space, Postoperative complications, Respiratory DepressionPostoperative analgesic combination - Ropivacaine 200 ml/400 mg + Morphine for continuous epidural infusion for the first 5 days.The infusion will start 2 hours before the end of the operation and before the admission to the intensive care unit. | Procedure or surgery | Analgesic Combination-Morphine&Ropivacaine 0.2% |
Primary outcome
Pain Relief
Time frame: From first postoperative day to the fifth postoperative day.
Using the NRS scale the analgesic combination outcome will be measured and reported with zero being equivalent to no pain and ten being the worst possible pain.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Oct 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Abdomen Cancer
RecruitingPhase 2
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Ovarian Cancer, Fallopian Tube Cancer
Not yet recruiting
Nurse-Led Prehabilitation Before Major Abdominal Cancer Surgery
Colorectal Cancer
RecruitingPhase 1
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Adrenocortical Carcinoma (ACC), Recurrent Adrenocortical Carcinoma (ACC)
RecruitingPhase 1
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Peritoneal Mesothelioma, Peritoneal Carcinomatosis
RecruitingPhase 3
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ovarian Neoplasms, Fallopian Tube Neoplasms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Epidural administered opioid in people with Abdomen Cancer and Pancreas Adenocarcinoma (MSI-H), run by National and Kapodistrian University of Athens at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 30 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact MARIA ZACHARIADI, MEDICAL DOCTOR (+35799760521, maria11095@yahoo.gr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain Relief (time frame: From first postoperative day to the fifth postoperative day.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2026.